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Melanocortin-1 Receptor Gene Variants Determine the Risk
of Nonmelanoma Skin Cancer Independently of Fair Skin and Red Hair
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Rudi G. J. Westendorp,2 Bert Jan Vermeer,1 and Jan Nico Bouwes Bavinck,1 for the Leiden
Skin Cancer Study Team*
Departments of 1Dermatology and 2Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands
Melanocortin-1 receptor (MC1R) gene variants are associated with fair skin and red hair and, independently of
these, with cutaneous malignant melanoma. The association of MC1R gene variants with nonmelanoma skin cancer
is largely unknown. A total of 838 subjects were included in the present study: 453 patients with nonmelanoma
skin cancer and 385 subjects with no skin cancer. The coding sequence of the human MC1R gene was tested using
single-stranded conformation polymorphism analysis followed by sequencing of unknown variants. Risk of skin
cancer dependent on the various MC1R gene variants was estimated using the exposure odds ratio. We investigated
whether subjects with MC1R variant alleles were at increased risk of developing nonmelanoma skin cancer and,
if so, whether this increased risk was mediated by fair skin and red hair. A total of 27 MC1R gene variants were
found. The number of carriers of one, two, or three MC1R gene variants was 379 (45.2%), 208 (24.8%), and 7
(0.9%), respectively. A strong association between MC1R gene variants and fair skin and red hair was established,
especially the variants Arg151Cys and Arg160Trp ( ). Carriers of two variant alleles were at increasedP ! .0001
risk for developing cutaneous squamous cell carcinoma (odds ratio 3.77; 95% confidence interval [CI] 2.11–6.78),
nodular basal cell carcinoma (odds ratio 2.26; 95% CI 1.45–3.52), and superficial multifocal basal cell carcinoma
(odds ratio 3.43; 95% CI 1.92–6.15), compared with carriers of two wild-type alleles. Carriers of one variant allele
had half the risk. The highest relative risks of nonmelanoma skin cancer were found in carriers of the Asp84Glu,
His260Pro, and Asp294His variant alleles, and the risk was only slightly lower for carriers of the Val60Leu,
Val92Met, Arg142His, Arg151Cys, and Arg160Trp variant alleles. When subjects were stratified by skin type and
hair color, analysis showed that these factors did not materially change the relative risks. These findings indicate
that MC1R gene variants are important independent risk factors for nonmelanoma skin cancer.
Introduction
Cutaneous squamous cell carcinomas and basal cell car-
cinomas, together commonly called “nonmelanoma skin
cancer,” are among the most common cancers in white
populations (Preston and Stern 1992). Basal cell carci-
nomas can be subdivided into nodular and superficial
multifocal basal cell carcinoma, for both of which the
distribution varies according to age, sex, and site (Bas-
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tiaens et al. 1998). Ultraviolet (UV) radiation is the ma-
jor environmental risk factor of nonmelanoma skin can-
cer (Kricker et al. 1994), whereas fair skin and red hair
are considered to be the most important genetically de-
termined risk factors (Kricker et al. 1991).
Melanocortin-1 receptor (MC1R) gene variants
(MC1R [MIM 155555]), particularly the Arg151Cys,
Arg160Trp, and Asp294His variants, are associated
with fair skin and red hair (Valaverde 1995; Box et al.
1997). Fair skin and red hair are also associated with
an increased risk of cutaneous malignant melanoma
(Kricker et al. 1991; Bliss et al. 1995). Increased risks
of malignant melanoma have been shown in subjects
carrying different MC1R gene variant alleles (Valverde
et al. 1996; Healy et al. 1999; Palmer et al. 2000).
Carriers of the Asp84Glu variant allele were found to
have an increased risk of malignant melanoma in a
study reported by Valverde and coworkers (1996), but
later studies by the same research group (Healy et al.
1999) and by other research groups (Ichii-Jones et al.
1999; Palmer et al. 2000) were not able to confirm this
association. More recently, the Arg151Cys, Arg160Trp,
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Figure 1 Distribution of the MC1R gene variants in control subjects and the three nonmelanoma-skin-cancer groups. Blackened bars
indicate controls subjects; shaded bars indicate patients with squamous cell carcinoma; bars with slanted lines indicate patients with nodular
basal cell carcinoma; and unfilled bars indicate patients with superficial multifocal basal cell carcinoma.
and Asp294His variant alleles appeared to be associated
with an increased risk of malignant melanoma (Palmer
et al. 2000). The association between MC1R variants
and malignant melanoma suggests that the MC1R gene
is a susceptibility gene for this skin malignancy (Rees
and Healy 1997). The role of MC1R gene variants in
modulating the risk of nonmelanoma skin cancer, how-
ever, is largely unknown. In a small group of British
patients with nonmelanoma skin cancer, an overrepre-
sentation of the Asp294His variant allele was found
(Smith et al. 1998). Such an overrepresentation, how-
ever, could not be confirmed in a study of patients with
basal cell carcinoma (Ichii-Jones et al. 1999).
Melanin pigmentation plays an important role in pro-
tecting the skin against the damaging effects of UV ra-
diation. In humans, a-melanocyte–stimulating hormone
(a-MSH) and other pro-opiomelanocortin (POMC)
peptides, such as ACTH, modulate pigment metabolism
via MC1R (Suzuki et al. 1996; Thody and Graham
1998). The enhanced pigmentation of the skin after
UVB exposure is probably also mediated through a-
MSH and MSH receptors (Abdel-Malek et al. 1999).
Two pigments have been identified in human skin: the
black eumelanin and the red pheomelanin (Thody et al.
1991). Melanocytes, which are stimulated by a-MSH
acting through MC1R, synthesize the black eumelanin
pigment instead of red pheomelanin (Hunt et al. 1995).
Eumelanin is photoprotective, but pheomelanin may
contribute to skin carcinogenesis by producing free rad-
icals in response to UV radiation (Ranadive et al. 1986).
Individuals with red hair and fair skin predominantly
synthesize pheomelanin, which may explain their sun
sensitivity and inability to tan (Thody et al. 1991).
Apart from their function in pigment metabolism, a-
MSH and other POMC peptides also have immuno-
modulatory and anti-inflammatory activity (Wintzen
and Gilchrest 1996; Luger et al. 1998). In addition, a-
MSH affects proliferation and differentiation of mela-
nocytes (Lunec et al. 1990, 1992; De Luca et al. 1993;
Suzuki et al. 1996) and keratinocytes (Slominski et al.
1991).
The MC1R is a seven-pass transmembrane G-protein–
coupled receptor of 317 amino acids, which is expressed
in several cell types, including melanocytes and, possi-
bly, keratinocytes (Mountjoy et al. 1992; Chakraborty
and Pawelek 1993; Chakraborty et al. 1999b). Suzuki
et al. (1996), however, could not confirm by northern
blot analyses that human epidermal keratinocytes ex-
press MC1R mRNA. The human MC1R gene has been
cloned and localized to chromosome 16q24.3 (Gantz et
886 Am. J. Hum. Genet. 68:884–894, 2001
Table 1
Characteristics of the Study Population
Characteristic
Controls
(n p 385)
Any Type
of Skin Cancera
(n p 453)
Squamous Cell
Carcinoma
(n p 153)
Nodular Basal
Cell Carcinoma
(n p 284)
Superficial Multifocal
Basal Cell Carcinoma
(n p 142)
Sex (no. [%])
Male 163 [42.3] 254 [56.1] 99 [64.7] 162 [57.0] 74 [52.1]
Female 222 [57.7] 199 [43.9] 54 [35.3] 122 [43.0] 68 [47.9]
Age at interview (years):
Mean 58.5 63.0 66.2 63.3 60.4
Range 28.6–79.9 31.6–78.2 36.9–78.2 31.6–78.2 31.7–78.2
Skin type (no. [%]):b
IV: Tan, never burn 24 [6.2] 24 [5.3] 7 [4.6] 16 [5.6] 9 [6.3]
III: Tan, sometimes burn 181 [47.0] 167 [36.9] 46 [30.1] 107 [37.7] 50 [35.2]
II: Burn, then tan 155 [40.3] 202 [44.6] 76 [49.6] 123 [43.3] 61 [43.0]
I: Burn, never tan 25 [6.5] 60 [13.2] 24 [15.7] 38 [13.4] 22 [15.5]
Hair color at age 20 years (no. [%]):c
Black 27 [7.1] 22 [4.8] 5 [3.3] 16 [5.6] 7 [4.9]
Brown 97 [25.3] 79 [17.4] 13 [8.5] 58 [20.4] 28 [19.7]
Dark blond 143 [37.3] 162 [35.8] 55 [35.9] 94 [33.1] 46 [32.4]
Light blond 96 [25.1] 148 [32.7] 58 [37.9] 93 [32.8] 44 [31.0]
Red 20 [5.2] 42 [9.3] 22 [14.4] 23 [8.1] 17 [12.0]
a More than one type of skin cancer was present in 111 subjects (see text).
b Distribution compared with that in control subjects (P !.05).
c Not assessed in two control subjects.
al. 1993; Magenis et al. 1994). In the MC1R gene,
common polymorphisms have been identified (Valverde
et al. 1996; Box et al. 1997; Koppula et al. 1997). In
an Irish population, 175% of individuals tested had one
or more MC1R gene variants (Smith et al. 1998), sever-
al of which are able to alter the function of the receptor.
In mice, MC1R gene variants leading to loss of function
of the receptor result in an overproduction of pheo-
melanin and consequently yellow hair (Cone et al.
1996), whereas dominant variants extend the amount
of black pigment and diminish the amount of yellow
(Robbins et al. 1993). In humans, loss-of-function
variants have been identified (Val60Leu, Arg142His,
Arg151Cys, Arg160Trp, and Asp294His), which were
unable to stimulate cAMP production as strongly as the
wild-type receptor in response to a-MSH stimulation
(Fra¨ndberg et al. 1994, 1998; Schio¨th et al. 1999). Some
of these variant alleles have also been found to be as-
sociated with red hair and to be overrepresented in in-
dividuals with fair skin (Box et al. 1997; Smith et al.
1998; Flanagan et al. 2000; Palmer et al. 2000).
The purpose of the present study was to compare in-
dividuals who had nonmelanoma skin cancer with con-
trol subjects who had no history of skin cancer and to
focus on the presence of MC1R gene variants. We ex-
amined the association of MC1R gene variants with fair
skin and red hair. We then investigated whether subjects
with any MC1R variant alleles were at increased risk of
developing cutaneous squamous cell carcinoma, nodular
basal cell carcinoma, or superficial multifocal basal cell
carcinoma and, if so, whether this increased risk was
mediated by fair skin and red hair. Finally, we assessed
the relative risks of nonmelanoma skin cancer for carriers
of the individual MC1R-variant alleles.
Subjects and Methods
Study Population
The Leiden Skin Cancer Study (LSS) is an extensive
effort begun in 1997 to study environmental and genetic
risk factors for various skin cancers in the Dutch pop-
ulation. The medical ethics committees of Leiden Uni-
versity Medical Center (LUMC) and the other medical
centers involved approved the protocol, and all partic-
ipants gave informed consent.
Patients who were 30–80 years old and had histolog-
ically proved squamous cell carcinoma or nodular or su-
perficial multifocal basal cell carcinoma of the skin were
included in the study; tumors were newly diagnosed be-
tween January 1985 and December 1997 at the LUMC
Department of Dermatology or in three hospitals in the
same region as the LUMC (St. Franciscus Hospital in
Rotterdam, the Rijnland Hospital in Leiderdorp, and the
Westeinde Hospital in The Hague).
Control subjects in the same age range as the patients
were selected from the ophthalmology outpatient clinic
of the LUMC. They had no history of skin cancer, and
individuals with a history of intraocular melanoma were
excluded. Organ transplant recipients and patients with
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Table 2
Allele Frequencies of MC1R Gene Variants in the Various Skin Types
VARIANT (NUCLEOTIDE CHANGE)
SKIN TYPES I–IV
(np 1,676)
SKIN TYPE IV
(n p 96)
SKIN TYPE III
(n p 696)
SKIN TYPE II
(n p 714)
SKIN TYPE I
(n p 170) Pa
No. (%) of Patients with Skin Typea
Val60Leu (178GrT) 156 9 (9.4) 59 (8.5) 72 (10.1) 16 (9.4) .04
Asp84Glu (252CrA) 24 1 (1.0) 6 (.9) 14 (2.0) 3 (1.8) .10
Val92Met (284GrA) 146 6 (6.3) 58 (8.3) 62 (8.7) 20 (11.8) .004
Arg142His (425GrA) 13 0 (.0) 4 (.6) 7 (1.0) 2 (1.2) .41
Arg151Cys (451CrT) 133 1 (1.0) 27 (3.9) 60 (8.4) 25 (14.7) !.0001
Arg160Trp (478CrT) 189 7 (7.3) 53 (7.6) 97 (13.6) 32 (18.8) !.0001
Arg163Gln (488GrA) 75 4 (4.2) 29 (4.2) 34 (4.8) 8 (4.7) .22
His260Pro (779ArC) 13 1 (1.0) 5 (.7) 5 (.7) 2 (1.2) .61
Asp294His (880GrC) 19 0 (.0) 6 (.9) 8 (1.1) 5 (2.9) .02
Othersb 67 5 (5.2) 27 (3.9) 31 (4.3) 4 (2.4) .58
Frequency
(%)
All 35.5 39.2 54.7 68.8
NOTE.—n p no. of alleles.
a Calculated in a logistic regression model with the wild-type allele as the reference.
b Other variants, constituting !0.5% of total alleles, were as follows: Pro18Ala (52CrG), Ala81Pro (241GrC), Thr95Met (284CrT),
Gly104Ser (310GrA), Arg151Arg (453CrG), Ile155Thr (925TrC), Val173del, Val174Ile (981GrA), Pro230Leu (689CrT), Pro230Pro
(690GrA), Gln233Gln (699GrA), Ile264Ile (792CrT), Lys278Glu (832ArG), Asn279Ser (835ArG), Asn279Lys (836CrA), 86InsA, and
537InsC.
xeroderma pigmentosum or nevoid basal cell carcinoma
(Gorlin’s syndrome) were excluded, because these per-
sons are at greatly increased risk of skin cancer. For this
part of the study we also excluded all individuals with
a history of cutaneous malignant melanoma. Only pa-
tients and control subjects with skin types I through IV,
as defined by Fitzpatrick (1988), were included.
Interview and Physical Examination
Patients eligible for the study were asked by mail to
participate, and the participation of control subjects was
requested in a letter that was handed to them during a
visit to the ophthalmology outpatient clinic. All subjects
were contacted by telephone to arrange an appointment
at the dermatology outpatient clinic for the interview,
physical examination, and collection of a blood sample.
Trained interviewers performed a standardized per-
sonal interview. The invitation letter instructed partici-
pants not to mention during the interview and physical
examination whether they were treated for skin cancer.
Skin type was assessed as follows: always burn, never
tan (type I), always burn, then tan (type II), always tan,
sometimes burn (type III), and always tan, never burn
(type IV). Hair was assessed for its color at the age of
20 years and was classified into four categories: red, light
blond, dark blond, and brown or black.
The physical examination was performed by derma-
tologists, using a standard protocol. Eye color was cat-
egorized as brown, hazel/gray, green, or blue. If non-
melanoma skin cancer was found in control subjects,
they were grouped with the patients in all subsequent
analyses.
Detection of MC1R Gene Variants
Genomic DNA was isolated from peripheral blood
leukocytes, using routine methods (Miller et al. 1988).
The MC1R gene coding sequence (GenBank accession
number X65634) was amplified by PCR in the following
reaction: 200 ng genomic template DNA; 60 mM Tris
HCl (pH 10.0); 2.0 mM MgCl2; 15 mM (NH4)2SO4; 100
mM each dGTP, dTTP, dATP, and dCTP; 1 ml a-[32P]
dCTP (3,000 Ci mM1); 500 ng of each PCR primer; 2
U AmpliTaq (Applied Biosystems); and 10% DMSO in
a total volume of 100 ml. Samples were covered with
mineral oil, denatured for 4 min at 92C, and passed
through 33 cycles of amplification, consisting of 50 s of
denaturation at 92C, 50 s of primer annealing at 58C,
and 2 min of elongation at 72C. The amplifications
were performed in 0.5-ml tubes (Applied Biosystems).
The DNA sequences of the primers were as follows:
forward 5′-CAACGACTCCTTCCTGCTTC-3′ and re-
verse 5′-TGCCCAGCACACTTAAAGC-3′. The result-
ing 1,018-bp PCR fragments were digested by 2 U of
either RsaI or MspI and were screened for mutations by
SSCP analysis (Orita et al. 1989) on a 6% polyacryl-
amide gel with 10% glycerol. The gel analyses were per-
formed at room temperature for 6 h at 28 W or for 16
h at 20 W for MspI and RsaI digests, respectively.
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Table 3
Risk of Nonmelanoma Skin Cancer Dependent on MC1R Gene Variants Stratified According to Skin Type
CANCER AND GENOTYPE OR COMPARISONa SKIN TYPES I–IV
SKIN TYPES
I AND II
SKIN TYPES
III AND IV POOLED OR (95% CI) b
No. of Individuals
Controls Patients Controls Patients Controls Patients
Squamous cell carcinoma:
WT/WT 137 26 50 15 87 11
WT/Var 174 74 79 44 95 30
Var/Var 74 53 51 41 23 12
OR (95% CI)
WT/Var vs. WT/WT 2.24 (1.32–3.81) 1.86 (.89–3.91) 2.50 (1.12–5.67) 2.13 (1.25–3.68)
Var/Var vs. WT/WT 3.77 (2.11–6.78) 2.68 (1.25–5.80) 4.13 (1.47–11.70) 2.91 (1.62–5.58)
No. of Individuals
Controls Patients Controls Patients Controls Patients
Nodular basal cell carcinoma:
WT/WT 137 72 50 30 87 42
WT/Var 174 124 79 65 95 59
Var/Var 74 88 51 66 23 22
OR (95% CI)
WT/Var vs. WT/WT 1.36 (.92–1.99) 1.37 (.76–2.49) 1.29 (.76–2.17) 1.32 (.89–1.95)
Var/Var vs. WT/WT 2.26 (1.45–3.52) 2.16 (1.16–4.03) 1.98 (.94–4.19) 1.98 (1.23–3.19)
No. of Individuals
Controls Patients Controls Patients Controls Patients
Superficial multifocal basal cell carcinoma:
WT/WT 137 27 50 10 87 17
WT/Var 174 65 79 31 95 34
Var/Var 74 50 51 42 23 8
OR (95% CI)
WT/Var vs. WT/WT 1.90 (1.12–3.23) 1.96 (.83–4.71) 1.83 (.91–3.70) 1.87 (1.09–3.21)
Var/Var vs. WT/WT 3.43 (1.92–6.15) 4.12 (1.76–9.86) 1.78 (.61–5.09) 2.82 (1.45–5.22)
a WT p wild-type allele; Var p variant allele.
b Adjusted for skin type, using Mantel-Haenszel weighted OR.
Sequence Analysis
DNA samples for sequencing were obtained by PCR,
as described above, with the following M13-tailed
MC1R gene primers: M13MC1R-F (5′-TGTAAAA-
CGACGGCCAGTCAACGACTCCTTCCTGCTTC-3′)
and M13MC1R-IR (5′-CAGGAAACAGCTATGACC-
ATGAGTCACGATGCTGTGGTAGC-3′), resulting in
a 542-bp fragment, and the primers M13MC1R-IF (5′-
GACGTTGTAAACGACGGCCAGTACCTGCAGCTC-
CATGCTGTC-3′) and M13MC1R-R (5′-CAGGAAAC-
AGCTATGACCATGATGCCCAGCACACTTAAAGC-
3′), resulting in a 661-bp fragment.
Sequence analysis was performed on an ABI 377 au-
tomated DNA sequencer, using Big-Dye Terminator cy-
cle sequencing kits (Applied Biosystems) according to
the manufacturer’s protocol.
Statistical Analyses and Strategy of Analyses
Logistic regression analysis was used to compare
MC1R gene variants independently of skin type and hair
color in patients and control subjects. Exposure odds
ratios (ORs) with 95% confidence intervals (CIs) were
calculated to estimate the relative risk for the presence
and the number of the nonmelanoma skin cancer types
dependent on the MC1R gene variants. Further strati-
fication was performed on the basis of the following
hypotheses.
Hypothesis 1.—The first hypothesis was that the
MC1R-gene status determines skin type and red hair,
which determine the risk of skin cancer. In this line of
reasoning, skin type and hair color are considered con-
founding factors, and the association between MC1R
gene variants and nonmelanoma skin cancer is expected
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Table 4
Relative Risks of Squamous Cell Carcinoma and Nodular and Superficial Multifocal Basal Cell Carcinoma in Heterozygotes and
Compound Heterozygotes and Homozygotes for MC1R-Variant Alleles Compared with Homozygotes for the Wild-Type Allele
ALLELES
RISK (95% CI) IN INDIVIDUALS WITH
Squamous Cell Carcinoma Nodular Basal Cell Carcinoma
Superficial Multifocal Basal
Cell Carcinoma
Heterozygotes
Cpd Heterozygotes
and Homozygotes Heterozygotes
Cpd Heterozygotes
and Homozygotes Heterozygotes
Cpd Heterozygotes
and Homozygotes
WT homozygotes 1.0 1.0 1.0 1.0 1.0 1.0
Val60Leu 1.3 (.52–3.0) 5.0 (2.2–11.4) 1.1 (.61–2.1) 3.4 (1.8–6.7) 1.6 (.70–3.5) 4.3 (1.9–10.0)
Asp84Glu 7.0 (1.2–42.6) 7.9 (1.0–71.9) 4.4 (.99–22.4) 5.7 (1.0–42.1) 3.4 (.37–26.6) 10.2 (1.5–84.7)
Val92Met 2.4 (1.0–5.4) 3.1 (1.3–7.5) 1.4 (.70–2.6) 2.8 (1.4–5.4) 1.5 (.58–3.7) 3.5 (1.5–8.1)
Arg142His 0 (0–12.6) 3.5 (.39–27.7) 0 (0–4.4) 1.9 (.30–12.2) 0 (0–12.1) 6.8 (1.2–41.0)
Arg151Cys 2.2 (.79–6.1) 5.6 (2.4–12.9) 1.8 (.84–3.9) 2.8 (1.4–5.6) 2.4 (.89–6.4) 4.5 (1.9–10.7)
Arg160Trp 2.2 (1.1–4.6) 4.4 (2.1–9.1) 1.2 (.68–2.2) 1.5 (.77–2.8) 2.3 (1.1–4.6) 3.6 (1.7–7.6)
Arg163Gln 1.8 (.56–5.3) 1.2(.31–4.1) 0.95 (.37–3.4) 1.2 (.48–2.8) 2.0 (.67–5.6) 2.0 (.67–5.6)
His260Pro 7.9 (1.0–71.9) 5.2 (.0–200.4) 2.9 (.38–25.0) 7.6 (.78–182.2) 2.5 (.0–37.7) 5.1 (.0–192.7)
Asp294His 4.0 (.65–22.7) 26.4 (2.8–621.5) 0.95 (.12–6.2) 7.6 (.78–182.2) 1.3 (.20–7.2) 10.2 (.69–294.0)
NOTE—Cpd p compound; WT p wild type.
to disappear in strata of skin type (type I/II and III/IV)
and red hair (red and non-red). A Mantel-Haenszel
weighted OR was calculated to adjust ORs for the
MC1R gene variant according to skin type and hair
color.
Hypothesis 2.—The second hypothesis was that fair
skin and red hair are only indicators of the presence of
MC1R gene variants, and it is the gene variant that is
the true risk factor for skin cancer. If this hypothesis
were true, the association between skin type and non-
melanoma skin cancer and that between red hair and
nonmelanoma skin cancer would disappear within strata
of MC1R gene variants.
We decided to first analyze the association of any
MC1R variant allele (i.e., all variant alleles taken to-
gether) with nonmelanoma skin cancer. At a later stage
we analyzed the relative contribution of the individual
MC1R variant alleles to the nonmelanoma skin cancer
risk.
Hypothesis 3.—The third hypothesis was that fair
skin, red hair, and MC1R gene variants are independent
risk factors for nonmelanoma skin cancer. If the hy-
pothesis were correct an association would persist be-
tween MC1R gene variants and nonmelanoma skin can-
cer and between fair skin, red hair, and nonmelanoma
skin cancer in strata mentioned above.
Results
Composition of Study Population
A total of 889 participants were interviewed and ex-
amined at the dermatology outpatient clinic of the LUMC.
Of the subjects who agreed to participate in the study, 51
were excluded because they did not fulfill the inclusion
criteria. Among these, 26 individuals had a history solely
of basal cell carcinoma subtypes other than nodular and
superficial types, and in 4 individuals MC1R genotyping
was not successful, because no DNA or PCR product
could be obtained.
The final series for analyses comprised 838 subjects:
153 subjects with squamous cell carcinoma, 284 with
nodular basal cell carcinoma, and 142 with superficial
multifocal basal cell carcinoma; 385 control subjects
were studied. Of the 453 patients with skin cancer, 103
had only squamous cell carcinoma, 182 only nodular
basal cell carcinoma, and 57 only superficial multifocal
basal cell carcinoma. A total of 111 subjects had more
than one type of skin cancer: 26 had squamous cell car-
cinoma in combination with nodular basal cell carci-
noma, 9 had squamous cell carcinoma in combination
with superficial multifocal basal cell carcinoma, 15 had
squamous cell carcinoma in combination with both
types of basal cell carcinoma, and 61 had nodular in
combination with superficial multifocal basal cell car-
cinoma. In the analyses, patient groups consisted of sub-
jects with a certain skin cancer regardless of the history
of any other skin cancer; when patient groups consisting
of patients with only one type of skin cancer were an-
alyzed, similar relative risks were obtained.
Table 1 shows the characteristics of the study popu-
lation. As was expected, squamous cell carcinoma was
significantly associated with skin type ( ) andPp .0002
hair color ( ). Nodular basal cell carcinoma wasP ! .0001
significantly associated with skin type ( ), andPp .008
the P value approached a level that would indicate an
association with hair color ( ). Superficial multi-Pp .08
focal basal cell carcinoma was significantly associated
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Table 5
Risk of One or Multiple Nonmelanoma Skin Cancers on the Basis of MC1R Gene Variants
One Skin Tumor
Two to Four
Skin Tumors
Five or More
Skin Tumors
NO. OF INDIVIDUALS WITH
GENOTYPE OR COMPARISON Controls Patients Controls Patients Controls Patients
WT/WT 137 69 137 30 137 8
WT/Var 174 112 174 73 174 20
Var/Var 74 69 74 48 74 24
OR (95% CI)
WT/Var vs. WT/WT 1.28 (.86–1.89) 1.92 (1.15–3.19) 1.97 (.79–5.03)
Var/Var vs. WT/WT 1.85 (1.17–2.94) 2.96 (1.68–5.25) 5.55 (2.24–14.22)
a Wt p wild-type allele; Var p variant allele.
with both skin type ( ) and hair color (Pp .007 Pp
)..04
MC1R Gene Variants and the Association with Skin
Type and Hair Color
A total of 27 MC1R gene variants were found (table
2). Eighteen variants showed a frequency !.5% of total
alleles. Of the 1,676 alleles, only 8 showed two variants
within the same allele, a result observed in eight indi-
viduals. Of these eight individuals, seven also showed a
variant in the other allele, and in one individual the other
allele was the wild type. A polymorphism resulting from
an ArG synonymous substitution at nucleotide 942 was
found in 178 (10.6%) alleles. Because this substitution
did not alter the amino acid, A942G was not used as a
MC1R gene variant in the analyses. The Val92Met var-
iant was always observed together with the A942G
polymorphism.
Of the 838 participants, 244 (29.1%) had no MC1R
gene variants, 379 (45.2%) had one MC1R gene vari-
ant, 208 (24.8%) had two MC1R gene variants, and 7
(0.9%) had three MC1R gene variants. The group with
two variant alleles comprised 29 homozygotes and 179
compound heterozygotes. In the subjects with two var-
iant alleles, the frequencies of the combinations of the
MC1R gene variants did not materially differ from the
expected frequencies that were calculated from the allele
frequencies of the variants (data not shown). Therefore,
the MC1R gene variants found in the study can be con-
sidered independent variants and, consequently, were
analyzed as such.
The Arg151Cys and Arg160Trp variant alleles were
strongly associated with fair skin ( ). The var-P ! .0001
iants Val60Leu, Val92Met, and Asp294His were weak-
ly associated with skin type (table 2). Arg142His,
Arg151Cys, Arg160Trp, and Asp294His were strongly
associated with red hair ( ), whereas Asp84GluP ! .0001
and His260Pro were less strongly associated with red
hair ( and , respectively). No asso-Pp .004 Pp .008
ciations were found between any MC1R gene variants
and eye color (data not shown).
Association between All MC1R Gene Variants
Combined and Nonmelanoma Skin Cancer
Figure 1 shows the distribution of the MC1R gene
variants in the three nonmelanoma skin cancer groups
and the control subjects. Most of the variants were over-
represented in the skin cancer groups. Therefore, our
first analyses of MC1R gene variants and the nonme-
lanoma skin cancer groups were performed with all var-
iants combined.
Exposure ORs were calculated to explore whether the
presence of one or two MC1R gene variants is associated
with an elevated risk for nonmelanoma skin cancer. Ta-
ble 3 shows that MC1R gene variants were associated
with squamous cell carcinoma and with nodular and
superficial multifocal basal cell carcinoma.
Testing Hypothesis 1
Stratified analyses were performed in subjects with fair
and dark skin and in subjects with and without red hair
to test the hypothesis that the association between
MC1R gene variants and nonmelanoma skin cancer is
mediated via fair skin and red hair. The positive asso-
ciation between MC1R gene variants and nonmelanoma
skin cancer generally remained in both fair and dark
skin strata (table 3) and also in the strata with and with-
out red hair (data not shown), a result indicating that
the presence of MC1R gene variants is a risk fac-
tor for nonmelanoma skin cancer, independently of fair
skin and red hair. The risk of superficial multifocal basal
cell carcinoma in carriers of two MC1R gene variants,
however, appeared to be lower among subjects with
darker skin compared with lighter skin (i.e., 1.78 vs.
4.12, respectively) (table 3). Unfortunately, in this sub-
group analysis, the wide CIs indicate that the number
of individuals is too small to conclude that the associ-
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ation between MC1R gene variants and superficial mul-
tifocal basal cell carcinoma was different among subjects
with fair and dark skin. It was also not possible to con-
clude that the behavior of basal cell carcinoma differs
from that of squamous cell carcinoma. It is conceivable
that among subjects with darker skin the lower relative
risk of superficial multifocal basal cell carcinoma in car-
riers of two MC1R gene variants was caused by chance.
The pooled ORs adjusted for skin type by use of the
Mantel-Haenszel test were only slightly lower than the
crude OR (table 3), which also strongly supports the
conclusion that the association between MC1R gene var-
iants and nonmelanoma skin cancer is independent of
skin type.
Testing Hypothesis 2
The risk of squamous cell carcinoma in subjects with
fair skin (skin types I and II) compared with dark skin
(skin types III and IV) was 2.15 (95% CI 1.43–3.23).
For nodular basal cell carcinoma and superficial multi-
focal basal cell carcinoma, these figures were 1.49
(1.08–2.05) and 1.60 (1.07–2.41), respectively. In all
three MC1R-gene strata, fair skin remained a risk fac-
tor for the nonmelanoma skin cancers, indicating that
fair skin is a risk factor for nonmelanoma skin cancer
independently of MC1R gene variants. Analyses per-
formed in subjects with red hair revealed similar results
(data not shown).
Testing Hypothesis 3
From the results of the analyses investigating an
association between MC1R gene variants and the dif-
ferent types of nonmelanoma skin cancer, and be-
tween fair skin, red hair, and nonmelanoma skin can-
cer, we conclude that MC1R gene variants, fair skin,
and red hair were independent risk factors for non-
melanoma skin cancer.
Association between Different MC1R Gene Variants
and Nonmelanoma Skin Cancer
Table 4 shows separate analyses with the individual
MC1R-variant alleles. The risks of skin cancer for het-
erozygotes and compound heterozygotes and homo-
zygotes compared with that of subjects who are ho-
mozygous for the wild-type allele are listed. Generally,
all MC1R gene variants were associated with an in-
creased risk of nonmelanoma skin cancer although sta-
tistical significance was not reached for all comparisons,
especially when the less-prevalent alleles were tested.
Overall, the highest relative risks of nonmelanoma skin
cancer were observed in carriers of the Asp84Glu,
His260Pro, and Asp294His variant alleles. Slightly
lower risks were observed in carriers of the Val60Leu,
Val92Met, Arg142His, Arg151Cys, and Arg160Trp var-
iant alleles. Carriers of the Arg163Gln variant allele
showed the lowest relative risk, which did not reach
statistical significance in any of the comparisons.
Only the Arg151Cys and Arg160Trp variant al-
leles were strongly associated with fair skin, where-
as the Val60Leu, Asp84Glu, Val92Met, Arg142His,
His260Pro, and Asp294His variant alleles were weakly
associated or not associated with fair skin (table 2). Nev-
ertheless, all these variant alleles were associated with
skin cancer (table 4), which is an additional strong ar-
gument that skin type and nonmelanoma skin cancer
risk are independent outcomes of the presence of MC1R
gene variants. A similar line of argument holds for red
hair.
Association between MC1R Gene Variants and
Multiple Skin Tumors
To investigate whether carriers of MC1R gene variants
are at an increased risk of developing multiple non-
melanoma skin cancers, all patients were grouped to-
gether irrespective of the tumor type and were stratified,
according to the number of tumors, into three groups:
those with one tumor, those with two to four tumors,
and those with five or more tumors. The presence of
MC1R gene variants was significantly and indepen-
dently associated with higher numbers of skin tumors
(table 5). Subsequent analyses of each type of skin cancer
separately showed that this effect was mostly caused by
the occurrence of squamous cell carcinoma and super-
ficial multifocal basal cell carcinoma (data not shown).
Discussion
Until now, fair skin and red hair have been considered
to be the most important genetically determined indi-
cators of increased risk of nonmelanoma skin cancer and
malignant melanoma (Kricker et al. 1991; Bliss et al.
1995). In the present study, however, we demonstrate
that the presence of MC1R gene variants are also im-
portant in modulating an individual’s risk of developing
any of the three nonmelanoma skin cancers studied. Al-
though the strong association of MC1R gene variants
with fair skin and red hair could be confirmed convinc-
ingly, our analyses also showed that these factors did
not materially influence the association between MC1R
gene variants and nonmelanoma skin cancer, a result
that undermines hypothesis 1: that the increased risk of
nonmelanoma skin cancer is mediated via the pigmen-
tation phenotype.
On the other hand, the association of fair skin and
red hair with nonmelanoma skin cancer was not influ-
enced by the presence of MC1R gene variants. This rules
out hypothesis 2, that fair skin and red hair are merely
indicators of the presence of MC1R gene variants and
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that the latter factor is the true risk factor for skin
cancer.
Therefore, we conclude that MC1R gene variants, fair
skin, and red hair are independent risk factors for non-
melanoma skin cancer (thereby verifying hypothesis 3).
This conclusion is in agreement with a recent study in
which the MC1R gene variants Arg151Cys, Arg160Trp,
and Asp294His were found to be associated with cu-
taneous malignant melanoma in an Australian popu-
lation and in which the association persisted in indi-
viduals with medium or olive/dark complexions (Palmer
et al. 2000).
The present data suggest that the MC1R plays an
important role in the pathogenesis not only of cutaneous
malignant melanoma but also of cutaneous squamous
cell carcinoma and both types of basal cell carcinoma
studied. Carriers of two MC1R gene variants among
subjects with darker skin (skin types III and IV) showed
a lower risk of superficial multifocal basal cell carci-
noma compared with carriers with lighter skin (skin
types I and II). Unfortunately, the number of individuals
in this subgroup analysis was too small to determine
whether the observed difference between the two skin
types represented a true difference or had occurred as
a result of chance.
Separate analyses of the individual MC1R variant
alleles showed that all of the more common variant
alleles were associated with an increased risk of non-
melanoma skin cancer. The highest relative risks of non-
melanoma skin cancer were found in carriers of the
Asp84Glu, His260Pro, and Asp294His variant alleles,
and the risk was only slightly lower for carriers of the
Val60Leu, Val92Met, Arg142His, Arg151Cys, and
Arg160Trp variant alleles. With the exception of the
Arg151Cys and Arg160Trp variant alleles, these alleles
were weakly associated or not associated with fair skin,
which further illustrates the finding that fair skin and
nonmelanoma skin cancer are independent outcomes of
MC1R gene variants. A similar line of argument applies
to red hair.
Some MC1R gene variants are associated with fair
skin and red hair, and individuals with this pigmenta-
tion phenotype predominantly synthesize pheomelanin
instead of eumelanin in their melanocytes after stimu-
lation by a-MSH (Thody et al. 1991). Eumelanin is
photoprotective, but pheomelanin may contribute to
skin carcinogenesis by producing free radicals in re-
sponse to UV radiation (Ranadive et al. 1986). Free
radicals and other reactive oxygen species have been
found to cause many types of DNA damage, including
single- and double-stranded DNA breaks, which have
been implicated in pathological processes such as cancer
(Shackelford et al. 2000). Our study, however, indicated
that the increased risk of nonmelanoma skin cancer
probably is not mediated via pigmentation phenotype.
Therefore, apart from pigment metabolism, other mech-
anisms must be involved in the relationship between
MC1R gene variants and the susceptibility of nonmel-
anoma skin cancer.
It is well documented that a-MSH and other POMC
peptides have immunomodulatory and anti-inflamma-
tory functions (Wintzen and Gilchrest, 1996; Luger et
al. 1997). Within a mouse model, a-MSH was able to
inhibit the induction of a contact hypersensitivity re-
action and to induce hapten-specific tolerance (Luger et
al. 1999). Also, a-MSH has been shown to play a role
in modulating the transcription factor NFkB, which reg-
ulates the expression of gene products, such as cytokines
and their receptors, that are involved in immune and
inflammatory responses (Kalden et al. 1999). UV light
induces the release of a-MSH and other POMC pep-
tides and up-regulates the expression of MC1R in the
epidermis (Chakraborty et al. 1995 and 1996) indicat-
ing that a-MSH may have a role in regulating responses
to UV radiation and inflammatory stimuli and that a-
MSH may contribute to UV-mediated immunosuppres-
sion (Luger et al. 1999).
It has been shown that a-MSH and other POMC
peptides influence growth and development of mela-
nocytes and melanoma cells (Lunec et al. 1990; Lunec
et al. 1992; De Luca et al. 1993; Suzuki et al. 1996) as
well as human keratinocytes (Slominski et al. 1991).
Differentiation-driven heat shock protein 70 in keratin-
ocytes was found to be down-regulated by a-MSH, ren-
dering them more sensitive to oxidative stress (Orel et
al. 1997). Recently, it was also found that the expression
of POMC peptides and their specific receptors was up-
regulated during keratinocyte differentiation, which
may indicate that a-MSH is part of a mediator network
that not only regulates cutaneous inflammation but also
plays a role in hyperproliferative skin diseases (Chak-
raborty et al. 1999a). In conclusion, we have shown
that the presence of MC1R gene variants is an important
independent genetic risk factor that contributes to the
risk of skin cancer.
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